中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2018 No. 5

Display Method:
Original articles_Liver fibrosis and liver cirrhosis
Value of serum alpha-fetoprotein in predicting liver fibrosis in patients with chronic hepatitis B
Cheng WanQiu, Guan ShiHe, Zhang Hao, Yang Kai, Chen ZhiDong, Shao XuanXuan
2018, 34(5): 1015-1019. DOI: 10.3969/j.issn.1001-5256.2018.05.018
Abstract:
Objective To investigate the correlation between serum alpha-fetoprotein ( AFP) and classification of liver fibrosis in patients with chronic hepatitis B ( CHB) , as well as the value of serum AFP in predicting liver fibrosis in CHB patients. Methods A total of 286 patients with a confirmed diagnosi...
Association of HBV precore/core promoter variants with the degree of liver fibrosis in patients with HBeAg-positive chronic hepatitis B
Shi HaiYan, Li LiYa, He HaoLan, Liu HuiYuan, Chen ZhiMin, Chen WeiLie, Liao BaoLin
2018, 34(5): 1020-1024. DOI: 10.3969/j.issn.1001-5256.2018.05.019
Abstract:
Objective To investigate the association of hepatitis B virus ( HBV) precore/core promoter variants with liver pathological changes in patients with HBe Ag-positive chronic hepatitis B ( CHB) . Methods A total of 148 HBe Ag-positive CHB patients who were hospitalized in Guangzhou Eighth People's Hos...
Original articles_Liver neoplasms
Clinical effect and safety of percutaneous radiofrequency ablation versus microwave ablation in treatment of hepatocellular carcinoma:a Meta-analysis
Yan JinZhu, Weng Hong, Zhang Chao, Wang Yuan, Yang Jian, Peng XinYu
2018, 34(5): 1025-1032. DOI: 10.3969/j.issn.1001-5256.2018.05.020
Abstract:
Objective To investigate the clinical effect and safety of percutaneous radiofrequency ablation ( RFA) versus microwave ablation ( MWA) in the treatment of hepatocellular carcinoma ( HCC) using the meta-analysis and trial sequential analysis ( TSA) . Methods Pub Med, The Cochrane Library ( Issue 6, ...
Risk factors for infectious complications in primary liver cancer
Liu HongJin, Bao ChunMei, Bai WenLin, Li YinYin, Rong GuangHua, Lu YinYing, Chen Yan, Liu Ze, Cheng JiaMin, Ceng Zhen
2018, 34(5): 1033-1037. DOI: 10.3969/j.issn.1001-5256.2018.05.021
Abstract:
Objective To investigate the risk factors for infectious complications in patients with primary liver cancer. Methods A retrospective analysis was performed for the clinical data of 3034 patients with primary liver cancer who were admitted to 302 Hospital of PLA from February 2016 to February 2017, ...
Risk factors for vascular invasion of primary liver cancer
Chang XiuJuan, Lu YinYing, Rong GuangHua, Liu Ze, Chen Yan, Xu GuiLin, Gao XuDong, Lou Min, Wang ChunPing, Yang YongPing, Ceng Zhen
2018, 34(5): 1038-1041. DOI: 10.3969/j.issn.1001-5256.2018.05.022
Abstract:
Objective To investigate the risk factors for vascular invasion of primary liver cancer ( PLC) . Methods A retrospective analysis was performed for the clinical data of 211 patients with liver cancer who were hospitalized in 302 Hospital of PLA from January 2013 to June 2014. The logistic regression...
Ultrasound features of hepatic inflammatory myofibroblastic tumor:a report of 4 cases
Shen Peng, Tang ShaoShan
2018, 34(5): 1042-1045. DOI: 10.3969/j.issn.1001-5256.2018.05.023
Abstract:
Objective To investigate the ultrasound features of hepatic inflammatory myofibroblastic tumor ( HIMT) . Methods A retrospective analysis was performed for the ultrasound features of 4 patients who visit Shengjing Hospital from February 2007 to July 2017 with pathologically confirmed HIMT, including...
Original articles_Biliary diseases
Value of preoperative and postoperative carbohydrate antigen 19-9 levels in predicting prognosis and early recurrence in patients with hilar cholangiocarcinoma
Cha YuFeng, He XiaoHu, Tian Mian, Gao Jun, Wang Gang
2018, 34(5): 1046-1051. DOI: 10.3969/j.issn.1001-5256.2018.05.024
Abstract:
Objective To investigate the value of preoperative and postoperative carbohydrate antigen 19-9 ( CA19-9) levels in predicting the prognosis and early recurrence of patients with hilar cholangiocarcinoma ( HCCA) . Methods A total of 80 patients with HCCA who underwent radical resection in The Second ...
Case reports
Traditional Chinese medicine treatment of methotrexate-induced liver injury with liver cirrhosis:a case report
Chen Xi, Lu Lu, Gu HongTu, Sun MingYu
2018, 34(5): 1080-1082. DOI: 10.3969/j.issn.1001-5256.2018.05.030
Abstract:
Intraductal papillary neoplasm of bile ducts with focal cancer infiltration:a case report
Liu ShouLing, Zhang JianWei, Wu Hao, Zhou JianPeng, Wei Feng, Wang GuangYi
2018, 34(5): 1083-1085. DOI: 10.3969/j.issn.1001-5256.2018.05.031
Abstract:
Roxithromycin-induced autoimmune hepatitis:a case report
Sheng JianHui, Sun Li, Tan HuiYing, Tan YouWen
2018, 34(5): 1086-1087. DOI: 10.3969/j.issn.1001-5256.2018.05.032
Abstract:
Systemic lupus erythematosus with primary biliary cholangitis:a case report
Wei LiNa, Song Jie, Ma JingTing, Zhao Rui, Wang WuDong, Li DongFu
2018, 34(5): 1088-1090. DOI: 10.3969/j.issn.1001-5256.2018.05.033
Abstract:
A case of liver injury due to intravenous injection of amiodarone
Zhang WenYing, Xu Yan, Shu Bing
2018, 34(5): 1091-1093. DOI: 10.3969/j.issn.1001-5256.2018.05.034
Abstract:
IgG4-associated sclerosing cholangitis misdiagnosed as hilar cholangiocarcinoma:a case report
Xie QianKun, Shi XiaoJu, Hu YueLei, Chai WenGang, Lu: GuoYue
2018, 34(5): 1094-1095. DOI: 10.3969/j.issn.1001-5256.2018.05.035
Abstract:
Incisional pyogenic granuloma with hyaline change after biliary exploration:a case report
Xie ZhiQin, Wang TaoLi, Chen Xun, Li HongXia, Tang CaiXi, Zhu ZeMin
2018, 34(5): 1096-1097. DOI: 10.3969/j.issn.1001-5256.2018.05.036
Abstract:
Reviews
Development and prospects of pathological classification systems for chronic hepatitis
Chen YangYi, Liu ChengHai
2018, 34(5): 1098-1102. DOI: 10.3969/j.issn.1001-5256.2018.05.037
Abstract:
Liver pathology is the gold standard for the diagnosis of chronic hepatitis. Although there are many effective noninvasive diagnostic methods, liver pathology is still the most direct and reliable method for evaluating inflammation and fibrosis in patients with chronic hepatitis.The classification s...
Research advances in the role of OX40/OX40L in the immune pathogenesis of chronic hepatitis
Qin Wei, Zhao CaiYan, Yang Zhao, Zhu SuPing, Li MuSong, Huo YuLing
2018, 34(5): 1103-1106. DOI: 10.3969/j.issn.1001-5256.2018.05.038
Abstract:

The development and progression of chronic hepatitis are closely associated with the immune function of human body, and T cells play an important role in this process. Costimulatory molecules OX40/OX40 L are involved in the activation of T cells. This article reviews the molecular features of OX40/O...

Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt
Ding ZhiFeng, Yin ShiWu
2018, 34(5): 1107-1110. DOI: 10.3969/j.issn.1001-5256.2018.05.039
Abstract:

Transjugular intrahepatic portosystemic shunt ( TIPS) has been widely used in the treatment of the complications of portal hypertension, and in recent years, with a deepened understanding of TIPS, covered stents have been further developed and applied in clinical practice, among which a special sten...

Advances in the effect of B-type natriuretic peptide and its significance in patients with cirrhotic cardiomyopathy
Wang YaJie, Chen LiPing, Shang ZhiYin, Yang JingMao, Ai YingChun, Cheng JiLin
2018, 34(5): 1111-1114. DOI: 10.3969/j.issn.1001-5256.2018.05.040
Abstract:

Cirrhotic patients often have an increased cardiac load and impaired myocardial systolic and diastolic functions, which further cause abnormal myocardial structure, and such patients may develop the symptoms of heart failure under stress, which is called cirrhotic cardiomyopathy ( CCM) . This diseas...

The mechanism of chenodeoxycholic acid and its derivatives in hepatobiliary tumor
Qi Fei, Tang YingMei
2018, 34(5): 1115-1118. DOI: 10.3969/j.issn.1001-5256.2018.05.041
Abstract:

Chenodeoxycholic acid ( CDCA) is a primary bile acid and is involved in the digestion, transportation, and absorption of nutriments in the hepatobiliary system. Farnesoid X receptor ( FXR) is a member of the nuclear receptor superfamily. In vivo and in vitro studies have demonstrated that CDCA is th...

Current status and recent progress of second-line drugs for autoimmune hepatitis
Hu ZhiChao, Fan XiaoLi, Shen Yi, Yang Li
2018, 34(5): 1119-1122. DOI: 10.3969/j.issn.1001-5256.2018.05.042
Abstract:

Autoimmune hepatitis ( AIH) is an immune-mediated liver parenchymal inflammation with hepatocytes as target cells. Second-line drugs can be used for patients who have suboptimal response or intolerance to the standard treatment of AIH. This article reviews the research advances in second-line drugs ...

Current status of research on liver failure after liver cancer resection
Tang DeSheng, Li FuJun
2018, 34(5): 1123-1127. DOI: 10.3969/j.issn.1001-5256.2018.05.043
Abstract:

Liver failure is one of the most serious complications after liver cancer resection. Hemodynamic changes, bile salt imbalance, and impaired immune function can cause liver failure after liver cancer resection, and related risk factors include patient, liver, and surgical conditions. This article sum...

Association between intestinal dysbacteriosis and liver diseases
Hou Jing, Lu Yue, Zhang DeKai
2018, 34(5): 1128-1132. DOI: 10.3969/j.issn.1001-5256.2018.05.044
Abstract(2898) PDF (102KB)(565)
Abstract:

At present, studies have confirmed the closely relationship between liver diseases and intestinal flora, and regulation of intestinal flora has a certain effect on the progression and therapeutic outcome of liver diseases. With reference to the influencing mechanism of intestinal dysbacteriosis on l...

Research advances in the pathogenesis and surgical treatment of gallbladder carcinoma
Zhang FuBo, Zhang YaMin
2018, 34(5): 1133-1136. DOI: 10.3969/j.issn.1001-5256.2018.05.045
Abstract:

Gallbladder carcinoma ( GBC) is often obscured by some benign diseases in clinical practice and thus unsuspected GBC tends to occur. As for etiology, long-term stimulation by gallstones, gallbladder polyps larger than 1 cm, gallbladder adenoma, and adenomyomatosis of the gallbladder are closely asso...

Discussions by experts
Clinical value of anti-HBc quantification for chronic HBV infection
Hou FengQin, Wang GuiQiang
2018, 34(5): 915-918. DOI: 10.3969/j.issn.1001-5256.2018.05.001
Abstract:
As the achivement of a major project during the 12 th Five-year Plan Period in China, the technique of anti-HBc quantification has been approved for commercial use and holds promise for wide application in clinical practice. Chinese scholars have explored the clinical significance of anti-HBc in var...
New strategies for clinical cure and Institute of hepatitis B:viral suppression combined with immune modulation and its road map
Wu Di, Huang Da, Ning Qin
2018, 34(5): 919-925. DOI: 10.3969/j.issn.1001-5256.2018.05.002
Abstract:
Chronic hepatitis B virus ( HBV) infection remains a major global health issue. At present, nucleos ( t) ide analogues ( NAs) and interferon ( IFN) or pegylated interferon ( PEG-IFN) are used as the antiviral therapy. NA therapy is generally safe and well tolerated, but it has a high virological rec...
Antiviral therapeutic strategies for chronic hepatitis B patients with a normal alanine aminotransferase level
Ding Yang, Dou XiaoGuang
2018, 34(5): 926-929. DOI: 10.3969/j.issn.1001-5256.2018.05.003
Abstract:
Alanine aminotransferase ( ALT) is one of the most sensitive biochemical parameters used to reflect the degree of liver injury. It is generally believed that patients with hepatitis B virus ( HBV) infection and a normal ALT level are in the immune tolerance state, and no antiviral therapy is require...
Individualized treatment with pegylated interferon-α for chronic hepatitis B
Wan MoBin
2018, 34(5): 930-933. DOI: 10.3969/j.issn.1001-5256.2018.05.004
Abstract:
Antiviral therapy is the basic treatment of chronic hepatitis B, and pegylated interferon-α is one of the first-line treatment drugs. At present, several consensuses have been reached on individualized treatment with pegylated interferon-α, which is playing an important role in clinical practice. Ne...
Clinical significance of serum HBV RNA measurement in chronic hepatitis B patients
Lu FengMin, Dou XiaoGuang, Zhang WenHong, Wang FuSheng
2018, 34(5): 934-938. DOI: 10.3969/j.issn.1001-5256.2018.05.005
Abstract:
In the era of antiviral therapy with potent nucleos ( t) ide analogues ( NAs) , serum HBV DNA is reduced to a level below the lower limit of detection in most chronic hepatitis B ( CHB) patients, but the loss of serum HBV DNA only indicates that reverse transcription of virus is effectively inhibite...
Original articles_Viral hepatitis
Clinical effect of pegylated interferon α-2a in treatment of previously untreated HBeAg-positive chronic hepatitis B patients and related predictive factors
Lou Xin, Gao YuFeng, Ye Jun, Wang YinQiu, Guan ZiShu, Zou GuiZhou
2018, 34(5): 995-1000. DOI: 10.3969/j.issn.1001-5256.2018.05.014
Abstract:
Objective To investigate the clinical effect of pegylated interferon α-2 a ( PEG-IFNα-2 a) in the treatment of previously untreated HBeAg-positive chronic hepatitis B ( CHB) patients and related predictive factors. Methods A retrospective analysis was performed for 111 previously untreated HBeAg-pos...
Association between HBsAg clearance and serum level of granulocyte-macrophage colony stimulating factor in inactive HBsAg carriers receiving pegylated interferon alpha-2a
Cao ZhenHuan, Lu JunFeng, Wu YaLi, Zheng YanHong, Chen XinYue
2018, 34(5): 1001-1004. DOI: 10.3969/j.issn.1001-5256.2018.05.015
Abstract:
Objective To investigate the association between HBs Ag clearance and serum level of granulocyte-macrophage colony stimulating factor ( GM-CSF) in inactive HBs Ag carriers receiving pegylated interferon ( PEG-IFN) alpha-2 a. Methods A total of 20 inactive HBs Ag carriers who visited Beijing You An H...
Value of aspartate aminotransferase-to-platelet ratio index in judging the indication for antiviral therapy in patients with chronic HBV infection and alanine aminotransferase less than two times of upper limit of normal
Chen Chen, Zhai YuFeng, Zhang HuaiHong
2018, 34(5): 1005-1010. DOI: 10.3969/j.issn.1001-5256.2018.05.016
Abstract:

Objective To investigate the value of aspartate aminotransferase-to-platelet ratio index ( APRI) in judging the indication for antiviral therapy [liver inflammation grade ( G) ≥2 or fibrosis stage ( S) ≥2] in patients with chronic HBV infection and alanine aminotransferase ( ALT) < 2 × upper limi...

Effect of thymosin α1 on the function of CD4+CD25+CD127dim/- regulatory T cells in chronic hepatitis B patients
Li Yu, Tian Ying, Yang XiaoMei, Cao NingJia, Li Zhu, Zhang Hong, Zhang XianJiao
2018, 34(5): 1011-1014. DOI: 10.3969/j.issn.1001-5256.2018.05.017
Abstract:
Objective To investigate the effect of thymosin α1 therapy on the function of CD4+CD25+CD127dim/-regulatory T ( Treg) cells in chronic hepatitis B ( CHB) patients. Methods A total of 67 CHB patients who were admitted to Department of Infectious Diseases in Shaanxi Provincial People's Hospital from D...
Guidelines of prevention and treatment for alcoholic liver disease:a 2018 update
Fatty Liver Expert Committee,Chinese Medical Doctor Association, National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association
2018, 34(5): 939-946. DOI: 10.3969/j.issn.1001-5256.2018.05.006
Abstract(1646) PDF (335KB)(2062)
Abstract:
Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update
National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association, Fatty Liver Expert Committee,Chinese Medical Doctor Association
2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007
Abstract(2819) PDF (422KB)(2625)
Abstract:
An expert consensus for the management of chronic hepatitis B in Asian Americans(2018)
He CaiNi, Lu JingYi, Liu YiHao, Liu Yang, Ji FanPu
2018, 34(5): 958-965. DOI: 10.3969/j.issn.1001-5256.2018.05.008
Abstract:
Updated key points and clinical pathway for NCCN clinical practice guidelines in oncology: hepatobiliary cancers (Version 1.2018)
Li JuDong, Xu XinFei, Yu JiongJie, Xing Hao, Wu MengChao, Yang Tian
2018, 34(5): 966-977. DOI: 10.3969/j.issn.1001-5256.2018.05.009
Abstract:
An excerpt of American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis (2018)
Zhou Xin, Yang GuiYuan, Qian ZhuYin
2018, 34(5): 978-981. DOI: 10.3969/j.issn.1001-5256.2018.05.010
Abstract(496) PDF (188KB)(1168)
Abstract:
An excerpt of management of acute pancreatitis in the pediatric population: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee(2018)
Yan YanYan, Xie XinBao, Wang JianShe
2018, 34(5): 982-986. DOI: 10.3969/j.issn.1001-5256.2018.05.011
Abstract:
An excerpt of the NICE guidelines on pancreatic cancer in adults: diagnosis and management
Chen Yin, Yang GuiYuan, Qian ZhuYin
2018, 34(5): 987-990. DOI: 10.3969/j.issn.1001-5256.2018.05.012
Abstract:
An excerpt of ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts (2018)
Xie ZhiQin, Zhu ZeMin, Guo ZiYi, Liu ZhiYong, Tang CaiXi
2018, 34(5): 991-994. DOI: 10.3969/j.issn.1001-5256.2018.05.013
Abstract:
Influence of duration of plasma diafiltration on therapeutic outcome of liver failure
Yang XianShan, Zhou Li, Li Lu, Li Shuang, Kong Ming, Li ShanShan, Zou HuaiBin, Xu ManMan
2018, 34(5): 1052-1054. DOI: 10.3969/j.issn.1001-5256.2018.05.025
Abstract:
Objective To investigate the influence of different durations of plasma diafiltration ( PDF) on liver function in patients with liver failure and rebound of liver function after treatment. Methods A total of 101 patients with liver failure who were admitted to Beijing You An Hospital, Capital Medica...
Value of continuous monitoring of ICG-R15 in assessing hepatic insufficiency after partial hepatectomy
Luo YuJun, Zhang YaMin, Yang Long, Li Yan, Liu ZiRong
2018, 34(5): 1055-1059. DOI: 10.3969/j.issn.1001-5256.2018.05.026
Abstract:
Objective To investigate the value of indocyanine green retention rate at 15 minutes ( ICG-R15) immediately and at 3 and 5 days after partial hepatectomy in assessing the incidence of postoperative hepatic insufficiency. Methods This prospective study included70 patients with hepatocellular carcinom...
Effect of ghrelin O-acyltransferase inhibition by small interfering RNA on hepatocyte fatty degeneration and related mechanism of action
Zhang ShaoRen, Hu JingXian, Fan XiaoMing
2018, 34(5): 1060-1067. DOI: 10.3969/j.issn.1001-5256.2018.05.027
Abstract:
Objective To investigate the effect of inhibition of ghrelin O-acyltransferase ( GOAT) by small interfering RNA ( siRNA) on hepatocyte fatty degeneration and related mechanism of action. Methods Human LO2 hepatocytes were treated with free fatty acid ( FFA) to induce hepatocyte fatty degeneration. L...
Clinical features of acute schistosomiasis in China
Hu QinMing, Yang Zheng, Yuan Zhe, Yang ZhongMin
2018, 34(5): 1068-1074. DOI: 10.3969/j.issn.1001-5256.2018.05.028
Abstract:
Objective To investigate the clinical features of acute schistosomiasis in China, and to improve the understanding of this disease among clinicians. Methods CNKI was searched with “acute schistosomiasis”as a key word for Chinese articles published from January2000 to December 2016 to conduct a retro...
Mechanism of action of glutamine in portal hypertensive gastropathy in rats
Huang XiangJun, Wang YongHeng, Duan ShanShan, Li Lan, Sun GuoHui, Yang MeiYue, Leng DaYue, Zhang WenXing
2018, 34(5): 1075-1079. DOI: 10.3969/j.issn.1001-5256.2018.05.029
Abstract:
Objective To investigate the role and mechanism of action of glutamine in portal hypertension gastropathy ( PHG) in rats.Methods A total of 60 Sprague-Dawley rats were randomly divided into groups A ( sham-operation) , B ( sham-operation + glutamine) , C ( partial portal vein ligation) , and D ( par...